NanoViricides Inc. (NNVC)

[JG36]

While the FDA has often acted as an anchor on drug development, it can't be blamed for the glacial pace of Flucide development.

It is silly paranoia to say that the FDA regards drugs that attack a virus as "crazy talk", given that it has approved numerous antivirals that, in one way or another, interfere with a virus' ability to infect a cell and reproduce. It is not the FDA's fault that NNVC has yet to begin toxicity testing of Flucide.